FORMA Announces Collaboration with Novartis to Develop Inhibitors of Protein-Protein Interactions

News   Jan 13, 2009

 
FORMA Announces Collaboration with Novartis to Develop Inhibitors of Protein-Protein Interactions
 
 
 

RELATED ARTICLES

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug Candidate

News

Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.

READ MORE

Synaptic Proteins May Be Starting Point for Dementia Treatment

News

A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE